Matthew Goff Investment Advisor, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,114 filers reported holding NOVARTIS A G in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.

Quarter-by-quarter ownership
Matthew Goff Investment Advisor, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$8,507,522
+0.8%
83,522
-0.2%
2.05%
+3.3%
Q2 2023$8,443,407
+11.7%
83,673
+1.8%
1.98%
+5.7%
Q1 2023$7,559,220
+1.0%
82,165
-0.4%
1.88%
-3.8%
Q4 2022$7,484,747
+20.3%
82,504
+0.8%
1.95%
+9.7%
Q3 2022$6,224,000
-8.1%
81,888
+2.2%
1.78%
-2.4%
Q2 2022$6,772,000
+9.3%
80,114
+13.4%
1.82%
+25.4%
Q1 2022$6,198,000
+16.9%
70,628
+16.5%
1.45%
+19.7%
Q4 2021$5,304,000
+8.2%
60,635
+1.2%
1.22%
+1.1%
Q3 2021$4,902,000
-6.7%
59,945
+4.1%
1.20%
-9.9%
Q2 2021$5,256,000
+14.2%
57,606
+7.0%
1.33%
+2.8%
Q1 2021$4,602,000
-10.1%
53,842
-0.7%
1.30%
-14.8%
Q4 2020$5,119,000
+16.9%
54,204
+7.6%
1.52%
+9.0%
Q3 2020$4,379,000
+2.5%
50,359
+3.0%
1.40%
-0.3%
Q2 2020$4,271,000
+7.7%
48,906
+1.7%
1.40%
-16.1%
Q1 2020$3,965,000
+2.6%
48,092
+17.9%
1.67%
+16.7%
Q4 2019$3,864,000
+8.4%
40,803
-0.5%
1.43%
-2.8%
Q3 2019$3,564,000
-4.6%
41,014
+0.3%
1.47%
-7.9%
Q2 2019$3,734,000
-5.8%
40,894
-0.9%
1.60%
-12.6%
Q1 2019$3,966,000
+13.4%
41,257
+1.2%
1.83%
+2.9%
Q4 2018$3,498,000
+1.6%
40,763
+2.0%
1.78%
+28.8%
Q3 2018$3,443,000
+16.9%
39,957
+2.5%
1.38%
+19.8%
Q2 2018$2,945,000
+25.1%
38,988
+33.9%
1.15%
+16.7%
Q1 2018$2,354,000
+1.9%
29,115
+5.9%
0.99%
-0.6%
Q4 2017$2,309,000
+3.3%
27,496
+5.6%
0.99%
+3.4%
Q3 2017$2,235,000
+13.9%
26,028
+10.7%
0.96%
-45.5%
Q2 2017$1,962,000
+23.9%
23,506
+10.2%
1.76%
+16.2%
Q1 2017$1,584,00021,3331.51%
Other shareholders
NOVARTIS A G shareholders Q3 2020
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders